Author:
Moellering R. C.,Linden P. K.,Reinhardt J.,Blumberg E. A.,Bompart F.,Talbot G.H.
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference53 articles.
1. Leclercq, R., Derlot, E., Duval, J. & Courvalin, P. (1988). Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.New England Journal of Medicine319, 157–61.
2. Gaynes, R. & Edwards, J., The National Nosocomial Infection Surveillance (NNIS) System. (1996). Nosocomial vancomycin-resistant enterococci in the United States. 1989–1995. The first 1000 isolates. Infection Control Hospital Epidemiology17, 18.
3. Eng, R. H., Ng, K. & Smith, S. M. (1993). Susceptibility of resistant Enterococcus faecium to unusual antibiotics. Journal of Antimicrobial Chemotherapy31, 609–10.
4. Freeman, C., Robinson, A., Cooper, B., Mazens Sullivan, M., Quintiliani, R. & Nightingale, C. (1995). In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci. Diagnostic Microbiology and Infectious Disease21, 47–50.
5. Traub, W. H., Leonhard, B. & Bauer, D. (1993). Enterococcus faecium: in-vitro activity of antimicrobial drugs, singly and combined, with and without defibrinated human blood, against multiple-antibiotic-resistant strains. Chemotherapy39, 254–64.
Cited by
194 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献